nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ABCB1—Vismodegib—skin cancer	0.0909	0.182	CbGbCtD
Mefloquine—CYP3A4—Imiquimod—skin cancer	0.0786	0.157	CbGbCtD
Mefloquine—CYP3A4—Temozolomide—skin cancer	0.0786	0.157	CbGbCtD
Mefloquine—CYP2D6—Vemurafenib—skin cancer	0.0677	0.135	CbGbCtD
Mefloquine—CYP3A4—Vismodegib—skin cancer	0.0545	0.109	CbGbCtD
Mefloquine—ABCB1—Dactinomycin—skin cancer	0.0478	0.0954	CbGbCtD
Mefloquine—CYP3A4—Vemurafenib—skin cancer	0.0431	0.086	CbGbCtD
Mefloquine—HBA2—dermis—skin cancer	0.0285	0.119	CbGeAlD
Mefloquine—ABCB1—Docetaxel—skin cancer	0.0247	0.0493	CbGbCtD
Mefloquine—HBA1—forelimb—skin cancer	0.0203	0.0849	CbGeAlD
Mefloquine—HBA2—leg—skin cancer	0.0188	0.0785	CbGeAlD
Mefloquine—HBA2—forelimb—skin cancer	0.0187	0.0779	CbGeAlD
Mefloquine—HBA1—hindlimb—skin cancer	0.0183	0.0764	CbGeAlD
Mefloquine—HBA2—hindlimb—skin cancer	0.0168	0.0701	CbGeAlD
Mefloquine—HBA1—appendage—skin cancer	0.0157	0.0655	CbGeAlD
Mefloquine—CYP3A4—Docetaxel—skin cancer	0.0148	0.0295	CbGbCtD
Mefloquine—HBA2—appendage—skin cancer	0.0144	0.0601	CbGeAlD
Mefloquine—HBA2—endothelium—skin cancer	0.00869	0.0363	CbGeAlD
Mefloquine—HBA2—blood vessel—skin cancer	0.00802	0.0335	CbGeAlD
Mefloquine—HBA2—neck—skin cancer	0.00574	0.0239	CbGeAlD
Mefloquine—ADORA1—nerve—skin cancer	0.00459	0.0192	CbGeAlD
Mefloquine—HBA1—connective tissue—skin cancer	0.00448	0.0187	CbGeAlD
Mefloquine—HBA2—connective tissue—skin cancer	0.00411	0.0172	CbGeAlD
Mefloquine—HBA1—skin of body—skin cancer	0.00404	0.0169	CbGeAlD
Mefloquine—HBA2—epithelium—skin cancer	0.0039	0.0163	CbGeAlD
Mefloquine—HBA2—skin of body—skin cancer	0.00371	0.0155	CbGeAlD
Mefloquine—HBA1—lymphoid tissue—skin cancer	0.00327	0.0137	CbGeAlD
Mefloquine—HBA1—female reproductive system—skin cancer	0.00316	0.0132	CbGeAlD
Mefloquine—HBA2—lymphoid tissue—skin cancer	0.00301	0.0126	CbGeAlD
Mefloquine—HBA2—female reproductive system—skin cancer	0.0029	0.0121	CbGeAlD
Mefloquine—HBA1—head—skin cancer	0.00264	0.011	CbGeAlD
Mefloquine—HBA2—head—skin cancer	0.00242	0.0101	CbGeAlD
Mefloquine—HBA1—lymph node—skin cancer	0.00185	0.00771	CbGeAlD
Mefloquine—HBA2—lymph node—skin cancer	0.0017	0.00708	CbGeAlD
Mefloquine—ADORA2A—lymphoid tissue—skin cancer	0.00156	0.00653	CbGeAlD
Mefloquine—ADORA2A—female reproductive system—skin cancer	0.00151	0.0063	CbGeAlD
Mefloquine—ADORA1—female reproductive system—skin cancer	0.0013	0.00544	CbGeAlD
Mefloquine—BCHE—nipple—skin cancer	0.00127	0.00531	CbGeAlD
Mefloquine—ADORA2A—head—skin cancer	0.00126	0.00526	CbGeAlD
Mefloquine—CYP19A1—connective tissue—skin cancer	0.00125	0.00523	CbGeAlD
Mefloquine—ADORA1—head—skin cancer	0.00109	0.00455	CbGeAlD
Mefloquine—CYP19A1—female reproductive system—skin cancer	0.000884	0.00369	CbGeAlD
Mefloquine—ABCB1—blood vessel—skin cancer	0.000839	0.0035	CbGeAlD
Mefloquine—BCHE—skin of body—skin cancer	0.000815	0.0034	CbGeAlD
Mefloquine—ADORA1—lymph node—skin cancer	0.000762	0.00318	CbGeAlD
Mefloquine—ACHE—lymph node—skin cancer	0.000757	0.00316	CbGeAlD
Mefloquine—BCHE—mammalian vulva—skin cancer	0.000743	0.0031	CbGeAlD
Mefloquine—CYP19A1—head—skin cancer	0.000738	0.00308	CbGeAlD
Mefloquine—BCHE—female reproductive system—skin cancer	0.000636	0.00266	CbGeAlD
Mefloquine—Chills—Bleomycin—skin cancer	0.000614	0.00236	CcSEcCtD
Mefloquine—Dyspnoea—Imiquimod—skin cancer	0.00061	0.00235	CcSEcCtD
Mefloquine—Somnolence—Imiquimod—skin cancer	0.000608	0.00234	CcSEcCtD
Mefloquine—Hepatobiliary disease—Temozolomide—skin cancer	0.000608	0.00234	CcSEcCtD
Mefloquine—Alopecia—Bleomycin—skin cancer	0.000604	0.00233	CcSEcCtD
Mefloquine—Erythema multiforme—Dactinomycin—skin cancer	0.000603	0.00232	CcSEcCtD
Mefloquine—Dyspepsia—Imiquimod—skin cancer	0.000602	0.00232	CcSEcCtD
Mefloquine—Pneumonia—Fluorouracil—skin cancer	0.000596	0.00229	CcSEcCtD
Mefloquine—Erythema—Bleomycin—skin cancer	0.000596	0.00229	CcSEcCtD
Mefloquine—Decreased appetite—Imiquimod—skin cancer	0.000595	0.00229	CcSEcCtD
Mefloquine—Flushing—Dactinomycin—skin cancer	0.000592	0.00228	CcSEcCtD
Mefloquine—Hypersensitivity—Vemurafenib—skin cancer	0.000591	0.00227	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000591	0.00227	CcSEcCtD
Mefloquine—Fatigue—Imiquimod—skin cancer	0.00059	0.00227	CcSEcCtD
Mefloquine—Visual disturbance—Docetaxel—skin cancer	0.000585	0.00225	CcSEcCtD
Mefloquine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000581	0.00223	CcSEcCtD
Mefloquine—Dermatitis bullous—Docetaxel—skin cancer	0.00058	0.00223	CcSEcCtD
Mefloquine—Asthenia—Vemurafenib—skin cancer	0.000576	0.00221	CcSEcCtD
Mefloquine—Hallucination—Temozolomide—skin cancer	0.000574	0.00221	CcSEcCtD
Mefloquine—Chills—Dactinomycin—skin cancer	0.000572	0.0022	CcSEcCtD
Mefloquine—Pruritus—Vemurafenib—skin cancer	0.000568	0.00218	CcSEcCtD
Mefloquine—Connective tissue disorder—Temozolomide—skin cancer	0.000567	0.00218	CcSEcCtD
Mefloquine—Alopecia—Dactinomycin—skin cancer	0.000564	0.00217	CcSEcCtD
Mefloquine—Feeling abnormal—Imiquimod—skin cancer	0.000564	0.00217	CcSEcCtD
Mefloquine—Gastrointestinal pain—Imiquimod—skin cancer	0.000559	0.00215	CcSEcCtD
Mefloquine—Visual impairment—Temozolomide—skin cancer	0.000556	0.00214	CcSEcCtD
Mefloquine—Erythema—Dactinomycin—skin cancer	0.000555	0.00214	CcSEcCtD
Mefloquine—Agranulocytosis—Fluorouracil—skin cancer	0.000553	0.00213	CcSEcCtD
Mefloquine—Ill-defined disorder—Bleomycin—skin cancer	0.000553	0.00213	CcSEcCtD
Mefloquine—Diarrhoea—Vemurafenib—skin cancer	0.000549	0.00211	CcSEcCtD
Mefloquine—Erythema multiforme—Temozolomide—skin cancer	0.000546	0.0021	CcSEcCtD
Mefloquine—Urticaria—Imiquimod—skin cancer	0.000543	0.00209	CcSEcCtD
Mefloquine—Abdominal pain—Imiquimod—skin cancer	0.000541	0.00208	CcSEcCtD
Mefloquine—Body temperature increased—Imiquimod—skin cancer	0.000541	0.00208	CcSEcCtD
Mefloquine—Eye disorder—Temozolomide—skin cancer	0.000539	0.00207	CcSEcCtD
Mefloquine—Tinnitus—Temozolomide—skin cancer	0.000538	0.00207	CcSEcCtD
Mefloquine—Malaise—Bleomycin—skin cancer	0.000537	0.00207	CcSEcCtD
Mefloquine—Flushing—Temozolomide—skin cancer	0.000536	0.00206	CcSEcCtD
Mefloquine—Cardiac disorder—Temozolomide—skin cancer	0.000536	0.00206	CcSEcCtD
Mefloquine—Leukopenia—Bleomycin—skin cancer	0.000533	0.00205	CcSEcCtD
Mefloquine—BCHE—head—skin cancer	0.000532	0.00222	CbGeAlD
Mefloquine—Dizziness—Vemurafenib—skin cancer	0.00053	0.00204	CcSEcCtD
Mefloquine—Angiopathy—Temozolomide—skin cancer	0.000524	0.00201	CcSEcCtD
Mefloquine—Ataxia—Docetaxel—skin cancer	0.000522	0.00201	CcSEcCtD
Mefloquine—Mediastinal disorder—Temozolomide—skin cancer	0.00052	0.002	CcSEcCtD
Mefloquine—Chills—Temozolomide—skin cancer	0.000518	0.00199	CcSEcCtD
Mefloquine—CYP19A1—lymph node—skin cancer	0.000517	0.00216	CbGeAlD
Mefloquine—Ill-defined disorder—Dactinomycin—skin cancer	0.000515	0.00198	CcSEcCtD
Mefloquine—Vomiting—Vemurafenib—skin cancer	0.00051	0.00196	CcSEcCtD
Mefloquine—Alopecia—Temozolomide—skin cancer	0.00051	0.00196	CcSEcCtD
Mefloquine—Chest pain—Bleomycin—skin cancer	0.000507	0.00195	CcSEcCtD
Mefloquine—Myalgia—Bleomycin—skin cancer	0.000507	0.00195	CcSEcCtD
Mefloquine—Rash—Vemurafenib—skin cancer	0.000506	0.00195	CcSEcCtD
Mefloquine—Mental disorder—Temozolomide—skin cancer	0.000506	0.00195	CcSEcCtD
Mefloquine—Dermatitis—Vemurafenib—skin cancer	0.000505	0.00194	CcSEcCtD
Mefloquine—Hypersensitivity—Imiquimod—skin cancer	0.000504	0.00194	CcSEcCtD
Mefloquine—Headache—Vemurafenib—skin cancer	0.000503	0.00193	CcSEcCtD
Mefloquine—Malnutrition—Temozolomide—skin cancer	0.000502	0.00193	CcSEcCtD
Mefloquine—Erythema—Temozolomide—skin cancer	0.000502	0.00193	CcSEcCtD
Mefloquine—Discomfort—Bleomycin—skin cancer	0.000501	0.00193	CcSEcCtD
Mefloquine—Malaise—Dactinomycin—skin cancer	0.000501	0.00193	CcSEcCtD
Mefloquine—Cramp muscle—Docetaxel—skin cancer	0.0005	0.00192	CcSEcCtD
Mefloquine—Leukopenia—Dactinomycin—skin cancer	0.000497	0.00191	CcSEcCtD
Mefloquine—Asthenia—Imiquimod—skin cancer	0.000491	0.00189	CcSEcCtD
Mefloquine—Confusional state—Bleomycin—skin cancer	0.00049	0.00189	CcSEcCtD
Mefloquine—Oedema—Bleomycin—skin cancer	0.000486	0.00187	CcSEcCtD
Mefloquine—Anaphylactic shock—Bleomycin—skin cancer	0.000486	0.00187	CcSEcCtD
Mefloquine—Pruritus—Imiquimod—skin cancer	0.000484	0.00186	CcSEcCtD
Mefloquine—Nausea—Vemurafenib—skin cancer	0.000476	0.00183	CcSEcCtD
Mefloquine—Thrombocytopenia—Bleomycin—skin cancer	0.000476	0.00183	CcSEcCtD
Mefloquine—Vision blurred—Temozolomide—skin cancer	0.000473	0.00182	CcSEcCtD
Mefloquine—Myalgia—Dactinomycin—skin cancer	0.000473	0.00182	CcSEcCtD
Mefloquine—Tremor—Temozolomide—skin cancer	0.000471	0.00181	CcSEcCtD
Mefloquine—Alopecia—Fluorouracil—skin cancer	0.00047	0.00181	CcSEcCtD
Mefloquine—Diarrhoea—Imiquimod—skin cancer	0.000468	0.0018	CcSEcCtD
Mefloquine—Discomfort—Dactinomycin—skin cancer	0.000467	0.0018	CcSEcCtD
Mefloquine—Ill-defined disorder—Temozolomide—skin cancer	0.000466	0.00179	CcSEcCtD
Mefloquine—Erythema—Fluorouracil—skin cancer	0.000463	0.00178	CcSEcCtD
Mefloquine—Agitation—Temozolomide—skin cancer	0.000462	0.00178	CcSEcCtD
Mefloquine—Hypotension—Bleomycin—skin cancer	0.000454	0.00175	CcSEcCtD
Mefloquine—Oedema—Dactinomycin—skin cancer	0.000453	0.00174	CcSEcCtD
Mefloquine—Malaise—Temozolomide—skin cancer	0.000453	0.00174	CcSEcCtD
Mefloquine—Dizziness—Imiquimod—skin cancer	0.000452	0.00174	CcSEcCtD
Mefloquine—Vertigo—Temozolomide—skin cancer	0.000451	0.00174	CcSEcCtD
Mefloquine—Leukopenia—Temozolomide—skin cancer	0.00045	0.00173	CcSEcCtD
Mefloquine—Palpitations—Temozolomide—skin cancer	0.000444	0.00171	CcSEcCtD
Mefloquine—Thrombocytopenia—Dactinomycin—skin cancer	0.000444	0.00171	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000443	0.0017	CcSEcCtD
Mefloquine—Paraesthesia—Bleomycin—skin cancer	0.000436	0.00168	CcSEcCtD
Mefloquine—Vision blurred—Fluorouracil—skin cancer	0.000436	0.00168	CcSEcCtD
Mefloquine—Convulsion—Temozolomide—skin cancer	0.000435	0.00167	CcSEcCtD
Mefloquine—Vomiting—Imiquimod—skin cancer	0.000435	0.00167	CcSEcCtD
Mefloquine—Hypertension—Temozolomide—skin cancer	0.000434	0.00167	CcSEcCtD
Mefloquine—Dyspnoea—Bleomycin—skin cancer	0.000433	0.00167	CcSEcCtD
Mefloquine—Rash—Imiquimod—skin cancer	0.000431	0.00166	CcSEcCtD
Mefloquine—Dermatitis—Imiquimod—skin cancer	0.000431	0.00166	CcSEcCtD
Mefloquine—Pneumonia—Docetaxel—skin cancer	0.00043	0.00165	CcSEcCtD
Mefloquine—Headache—Imiquimod—skin cancer	0.000429	0.00165	CcSEcCtD
Mefloquine—CYP3A4—female reproductive system—skin cancer	0.000428	0.00179	CbGeAlD
Mefloquine—Myalgia—Temozolomide—skin cancer	0.000428	0.00165	CcSEcCtD
Mefloquine—Arthralgia—Temozolomide—skin cancer	0.000428	0.00165	CcSEcCtD
Mefloquine—Anxiety—Temozolomide—skin cancer	0.000426	0.00164	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000425	0.00163	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000424	0.00163	CcSEcCtD
Mefloquine—Discomfort—Temozolomide—skin cancer	0.000423	0.00163	CcSEcCtD
Mefloquine—Decreased appetite—Bleomycin—skin cancer	0.000422	0.00163	CcSEcCtD
Mefloquine—CYP2D6—female reproductive system—skin cancer	0.000422	0.00176	CbGeAlD
Mefloquine—Renal failure—Docetaxel—skin cancer	0.00042	0.00162	CcSEcCtD
Mefloquine—Neuropathy peripheral—Docetaxel—skin cancer	0.000419	0.00161	CcSEcCtD
Mefloquine—Leukopenia—Fluorouracil—skin cancer	0.000414	0.00159	CcSEcCtD
Mefloquine—Confusional state—Temozolomide—skin cancer	0.000413	0.00159	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000413	0.00159	CcSEcCtD
Mefloquine—Oedema—Temozolomide—skin cancer	0.00041	0.00158	CcSEcCtD
Mefloquine—Anaphylactic shock—Temozolomide—skin cancer	0.00041	0.00158	CcSEcCtD
Mefloquine—ABCB1—epithelium—skin cancer	0.000408	0.0017	CbGeAlD
Mefloquine—Nausea—Imiquimod—skin cancer	0.000406	0.00156	CcSEcCtD
Mefloquine—Hepatobiliary disease—Docetaxel—skin cancer	0.000404	0.00156	CcSEcCtD
Mefloquine—Nervous system disorder—Temozolomide—skin cancer	0.000402	0.00155	CcSEcCtD
Mefloquine—Thrombocytopenia—Temozolomide—skin cancer	0.000401	0.00154	CcSEcCtD
Mefloquine—Convulsion—Fluorouracil—skin cancer	0.000401	0.00154	CcSEcCtD
Mefloquine—Feeling abnormal—Bleomycin—skin cancer	0.000401	0.00154	CcSEcCtD
Mefloquine—Agranulocytosis—Docetaxel—skin cancer	0.000399	0.00153	CcSEcCtD
Mefloquine—Skin disorder—Temozolomide—skin cancer	0.000398	0.00153	CcSEcCtD
Mefloquine—Hyperhidrosis—Temozolomide—skin cancer	0.000396	0.00152	CcSEcCtD
Mefloquine—Myalgia—Fluorouracil—skin cancer	0.000394	0.00152	CcSEcCtD
Mefloquine—Chest pain—Fluorouracil—skin cancer	0.000394	0.00152	CcSEcCtD
Mefloquine—Decreased appetite—Dactinomycin—skin cancer	0.000394	0.00152	CcSEcCtD
Mefloquine—Fatigue—Dactinomycin—skin cancer	0.000391	0.0015	CcSEcCtD
Mefloquine—Discomfort—Fluorouracil—skin cancer	0.000389	0.0015	CcSEcCtD
Mefloquine—Urticaria—Bleomycin—skin cancer	0.000386	0.00149	CcSEcCtD
Mefloquine—Body temperature increased—Bleomycin—skin cancer	0.000384	0.00148	CcSEcCtD
Mefloquine—Confusional state—Fluorouracil—skin cancer	0.000381	0.00147	CcSEcCtD
Mefloquine—Anaphylactic shock—Fluorouracil—skin cancer	0.000378	0.00145	CcSEcCtD
Mefloquine—Oedema—Fluorouracil—skin cancer	0.000378	0.00145	CcSEcCtD
Mefloquine—Connective tissue disorder—Docetaxel—skin cancer	0.000377	0.00145	CcSEcCtD
Mefloquine—Feeling abnormal—Dactinomycin—skin cancer	0.000374	0.00144	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000374	0.00144	CcSEcCtD
Mefloquine—BCHE—lymph node—skin cancer	0.000372	0.00155	CbGeAlD
Mefloquine—Insomnia—Temozolomide—skin cancer	0.000371	0.00143	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000371	0.00143	CcSEcCtD
Mefloquine—Nervous system disorder—Fluorouracil—skin cancer	0.00037	0.00143	CcSEcCtD
Mefloquine—Thrombocytopenia—Fluorouracil—skin cancer	0.00037	0.00142	CcSEcCtD
Mefloquine—Visual impairment—Docetaxel—skin cancer	0.00037	0.00142	CcSEcCtD
Mefloquine—Tachycardia—Fluorouracil—skin cancer	0.000369	0.00142	CcSEcCtD
Mefloquine—Paraesthesia—Temozolomide—skin cancer	0.000368	0.00142	CcSEcCtD
Mefloquine—Dyspnoea—Temozolomide—skin cancer	0.000366	0.00141	CcSEcCtD
Mefloquine—Somnolence—Temozolomide—skin cancer	0.000364	0.0014	CcSEcCtD
Mefloquine—Erythema multiforme—Docetaxel—skin cancer	0.000363	0.0014	CcSEcCtD
Mefloquine—Dyspepsia—Temozolomide—skin cancer	0.000361	0.00139	CcSEcCtD
Mefloquine—Eye disorder—Docetaxel—skin cancer	0.000359	0.00138	CcSEcCtD
Mefloquine—Abdominal pain—Dactinomycin—skin cancer	0.000358	0.00138	CcSEcCtD
Mefloquine—Body temperature increased—Dactinomycin—skin cancer	0.000358	0.00138	CcSEcCtD
Mefloquine—Hypersensitivity—Bleomycin—skin cancer	0.000358	0.00138	CcSEcCtD
Mefloquine—Decreased appetite—Temozolomide—skin cancer	0.000356	0.00137	CcSEcCtD
Mefloquine—Cardiac disorder—Docetaxel—skin cancer	0.000356	0.00137	CcSEcCtD
Mefloquine—Flushing—Docetaxel—skin cancer	0.000356	0.00137	CcSEcCtD
Mefloquine—ABCB1—mammalian vulva—skin cancer	0.000354	0.00148	CbGeAlD
Mefloquine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000354	0.00136	CcSEcCtD
Mefloquine—Fatigue—Temozolomide—skin cancer	0.000353	0.00136	CcSEcCtD
Mefloquine—Hypotension—Fluorouracil—skin cancer	0.000353	0.00136	CcSEcCtD
Mefloquine—CYP2D6—head—skin cancer	0.000352	0.00147	CbGeAlD
Mefloquine—Asthenia—Bleomycin—skin cancer	0.000349	0.00134	CcSEcCtD
Mefloquine—Angiopathy—Docetaxel—skin cancer	0.000348	0.00134	CcSEcCtD
Mefloquine—Mediastinal disorder—Docetaxel—skin cancer	0.000346	0.00133	CcSEcCtD
Mefloquine—Chills—Docetaxel—skin cancer	0.000344	0.00132	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000344	0.00132	CcSEcCtD
Mefloquine—Pruritus—Bleomycin—skin cancer	0.000344	0.00132	CcSEcCtD
Mefloquine—Insomnia—Fluorouracil—skin cancer	0.000342	0.00131	CcSEcCtD
Mefloquine—Paraesthesia—Fluorouracil—skin cancer	0.000339	0.0013	CcSEcCtD
Mefloquine—Alopecia—Docetaxel—skin cancer	0.000339	0.0013	CcSEcCtD
Mefloquine—Feeling abnormal—Temozolomide—skin cancer	0.000338	0.0013	CcSEcCtD
Mefloquine—Dyspnoea—Fluorouracil—skin cancer	0.000337	0.0013	CcSEcCtD
Mefloquine—Mental disorder—Docetaxel—skin cancer	0.000336	0.00129	CcSEcCtD
Mefloquine—Somnolence—Fluorouracil—skin cancer	0.000336	0.00129	CcSEcCtD
Mefloquine—Gastrointestinal pain—Temozolomide—skin cancer	0.000335	0.00129	CcSEcCtD
Mefloquine—Malnutrition—Docetaxel—skin cancer	0.000334	0.00129	CcSEcCtD
Mefloquine—Erythema—Docetaxel—skin cancer	0.000334	0.00129	CcSEcCtD
Mefloquine—Hypersensitivity—Dactinomycin—skin cancer	0.000334	0.00128	CcSEcCtD
Mefloquine—Dyspepsia—Fluorouracil—skin cancer	0.000333	0.00128	CcSEcCtD
Mefloquine—Decreased appetite—Fluorouracil—skin cancer	0.000328	0.00126	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000326	0.00125	CcSEcCtD
Mefloquine—Urticaria—Temozolomide—skin cancer	0.000326	0.00125	CcSEcCtD
Mefloquine—Asthenia—Dactinomycin—skin cancer	0.000325	0.00125	CcSEcCtD
Mefloquine—Body temperature increased—Temozolomide—skin cancer	0.000324	0.00125	CcSEcCtD
Mefloquine—Abdominal pain—Temozolomide—skin cancer	0.000324	0.00125	CcSEcCtD
Mefloquine—Muscle spasms—Docetaxel—skin cancer	0.000321	0.00124	CcSEcCtD
Mefloquine—ABCB1—lymphoid tissue—skin cancer	0.000314	0.00131	CbGeAlD
Mefloquine—Feeling abnormal—Fluorouracil—skin cancer	0.000311	0.0012	CcSEcCtD
Mefloquine—Diarrhoea—Dactinomycin—skin cancer	0.00031	0.00119	CcSEcCtD
Mefloquine—Vomiting—Bleomycin—skin cancer	0.000309	0.00119	CcSEcCtD
Mefloquine—Rash—Bleomycin—skin cancer	0.000306	0.00118	CcSEcCtD
Mefloquine—Dermatitis—Bleomycin—skin cancer	0.000306	0.00118	CcSEcCtD
Mefloquine—ABCB1—female reproductive system—skin cancer	0.000303	0.00127	CbGeAlD
Mefloquine—Hypersensitivity—Temozolomide—skin cancer	0.000302	0.00116	CcSEcCtD
Mefloquine—Urticaria—Fluorouracil—skin cancer	0.0003	0.00115	CcSEcCtD
Mefloquine—Syncope—Docetaxel—skin cancer	0.0003	0.00115	CcSEcCtD
Mefloquine—Leukopenia—Docetaxel—skin cancer	0.000299	0.00115	CcSEcCtD
Mefloquine—Body temperature increased—Fluorouracil—skin cancer	0.000299	0.00115	CcSEcCtD
Mefloquine—Palpitations—Docetaxel—skin cancer	0.000295	0.00114	CcSEcCtD
Mefloquine—Asthenia—Temozolomide—skin cancer	0.000294	0.00113	CcSEcCtD
Mefloquine—Loss of consciousness—Docetaxel—skin cancer	0.000294	0.00113	CcSEcCtD
Mefloquine—Pruritus—Temozolomide—skin cancer	0.00029	0.00112	CcSEcCtD
Mefloquine—Convulsion—Docetaxel—skin cancer	0.000289	0.00111	CcSEcCtD
Mefloquine—Nausea—Bleomycin—skin cancer	0.000289	0.00111	CcSEcCtD
Mefloquine—Hypertension—Docetaxel—skin cancer	0.000288	0.00111	CcSEcCtD
Mefloquine—Vomiting—Dactinomycin—skin cancer	0.000288	0.00111	CcSEcCtD
Mefloquine—Rash—Dactinomycin—skin cancer	0.000286	0.0011	CcSEcCtD
Mefloquine—Myalgia—Docetaxel—skin cancer	0.000284	0.00109	CcSEcCtD
Mefloquine—Chest pain—Docetaxel—skin cancer	0.000284	0.00109	CcSEcCtD
Mefloquine—Arthralgia—Docetaxel—skin cancer	0.000284	0.00109	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000282	0.00109	CcSEcCtD
Mefloquine—Diarrhoea—Temozolomide—skin cancer	0.000281	0.00108	CcSEcCtD
Mefloquine—Hypersensitivity—Fluorouracil—skin cancer	0.000278	0.00107	CcSEcCtD
Mefloquine—Confusional state—Docetaxel—skin cancer	0.000275	0.00106	CcSEcCtD
Mefloquine—Anaphylactic shock—Docetaxel—skin cancer	0.000273	0.00105	CcSEcCtD
Mefloquine—Oedema—Docetaxel—skin cancer	0.000273	0.00105	CcSEcCtD
Mefloquine—Dizziness—Temozolomide—skin cancer	0.000271	0.00104	CcSEcCtD
Mefloquine—Nausea—Dactinomycin—skin cancer	0.000269	0.00104	CcSEcCtD
Mefloquine—Shock—Docetaxel—skin cancer	0.000268	0.00103	CcSEcCtD
Mefloquine—Nervous system disorder—Docetaxel—skin cancer	0.000267	0.00103	CcSEcCtD
Mefloquine—Pruritus—Fluorouracil—skin cancer	0.000267	0.00103	CcSEcCtD
Mefloquine—Thrombocytopenia—Docetaxel—skin cancer	0.000267	0.00103	CcSEcCtD
Mefloquine—Tachycardia—Docetaxel—skin cancer	0.000266	0.00102	CcSEcCtD
Mefloquine—Skin disorder—Docetaxel—skin cancer	0.000265	0.00102	CcSEcCtD
Mefloquine—Vomiting—Temozolomide—skin cancer	0.000261	0.001	CcSEcCtD
Mefloquine—Rash—Temozolomide—skin cancer	0.000258	0.000995	CcSEcCtD
Mefloquine—Diarrhoea—Fluorouracil—skin cancer	0.000258	0.000994	CcSEcCtD
Mefloquine—Dermatitis—Temozolomide—skin cancer	0.000258	0.000994	CcSEcCtD
Mefloquine—Headache—Temozolomide—skin cancer	0.000257	0.000988	CcSEcCtD
Mefloquine—Hypotension—Docetaxel—skin cancer	0.000255	0.00098	CcSEcCtD
Mefloquine—ABCB1—head—skin cancer	0.000253	0.00106	CbGeAlD
Mefloquine—Dizziness—Fluorouracil—skin cancer	0.00025	0.000961	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000248	0.000956	CcSEcCtD
Mefloquine—Insomnia—Docetaxel—skin cancer	0.000247	0.000949	CcSEcCtD
Mefloquine—Paraesthesia—Docetaxel—skin cancer	0.000245	0.000942	CcSEcCtD
Mefloquine—Nausea—Temozolomide—skin cancer	0.000244	0.000937	CcSEcCtD
Mefloquine—Dyspnoea—Docetaxel—skin cancer	0.000243	0.000935	CcSEcCtD
Mefloquine—Somnolence—Docetaxel—skin cancer	0.000242	0.000932	CcSEcCtD
Mefloquine—Vomiting—Fluorouracil—skin cancer	0.00024	0.000924	CcSEcCtD
Mefloquine—Dyspepsia—Docetaxel—skin cancer	0.00024	0.000923	CcSEcCtD
Mefloquine—Rash—Fluorouracil—skin cancer	0.000238	0.000916	CcSEcCtD
Mefloquine—Dermatitis—Fluorouracil—skin cancer	0.000238	0.000915	CcSEcCtD
Mefloquine—Decreased appetite—Docetaxel—skin cancer	0.000237	0.000912	CcSEcCtD
Mefloquine—Headache—Fluorouracil—skin cancer	0.000237	0.00091	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000235	0.000906	CcSEcCtD
Mefloquine—Fatigue—Docetaxel—skin cancer	0.000235	0.000904	CcSEcCtD
Mefloquine—Feeling abnormal—Docetaxel—skin cancer	0.000225	0.000864	CcSEcCtD
Mefloquine—Nausea—Fluorouracil—skin cancer	0.000224	0.000863	CcSEcCtD
Mefloquine—Gastrointestinal pain—Docetaxel—skin cancer	0.000223	0.000858	CcSEcCtD
Mefloquine—Body temperature increased—Docetaxel—skin cancer	0.000216	0.000829	CcSEcCtD
Mefloquine—Abdominal pain—Docetaxel—skin cancer	0.000216	0.000829	CcSEcCtD
Mefloquine—Hypersensitivity—Docetaxel—skin cancer	0.000201	0.000773	CcSEcCtD
Mefloquine—Asthenia—Docetaxel—skin cancer	0.000196	0.000753	CcSEcCtD
Mefloquine—Pruritus—Docetaxel—skin cancer	0.000193	0.000742	CcSEcCtD
Mefloquine—Diarrhoea—Docetaxel—skin cancer	0.000187	0.000718	CcSEcCtD
Mefloquine—Dizziness—Docetaxel—skin cancer	0.00018	0.000694	CcSEcCtD
Mefloquine—ABCB1—lymph node—skin cancer	0.000177	0.000741	CbGeAlD
Mefloquine—Vomiting—Docetaxel—skin cancer	0.000173	0.000667	CcSEcCtD
Mefloquine—Rash—Docetaxel—skin cancer	0.000172	0.000661	CcSEcCtD
Mefloquine—Dermatitis—Docetaxel—skin cancer	0.000172	0.000661	CcSEcCtD
Mefloquine—Headache—Docetaxel—skin cancer	0.000171	0.000657	CcSEcCtD
Mefloquine—Nausea—Docetaxel—skin cancer	0.000162	0.000623	CcSEcCtD
